| Wnt/β-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance M Ram Makena, H Gatla, D Verlekar, S Sukhavasi, M K. Pandey, ... International journal of molecular sciences 20 (17), 4242, 2019 | 129 | 2019 |
| Metabolic characteristics of 13‐cis‐retinoic acid (isotretinoin) and anti‐tumour activity of the 13‐cis‐retinoic acid metabolite 4‐oxo‐13‐cis‐retinoic acid in neuroblastoma P Sonawane, HE Cho, A Tagde, D Verlekar, AL Yu, CP Reynolds, ... British journal of pharmacology 171 (23), 5330-5344, 2014 | 35 | 2014 |
| Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia D Verlekar, SJ Wei, H Cho, S Yang, MH Kang Cell death & disease 9 (9), 925, 2018 | 31 | 2018 |
| MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma SJ Wei, TH Nguyen, IH Yang, DG Mook, MR Makena, D Verlekar, ... Cell death & disease 11 (5), 368, 2020 | 23 | 2020 |
| Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia MM Song, MR Makena, A Hindle, B Koneru, TH Nguyen, DU Verlekar, ... Anti-Cancer Drugs 30 (2), 117-127, 2019 | 13 | 2019 |
| Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies MR Makena, TH Nguyen, B Koneru, A Hindle, WH Chen, DU Verlekar, ... Anti-Cancer Drugs 32 (1), 34-43, 2021 | 11* | 2021 |
| Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines MR Makena, HE Cho, TH Nguyen, B Koneru, DU Verlekar, A Hindle, ... Pediatric blood & cancer 65 (12), e27447, 2018 | 6 | 2018 |
| Dihydroceramide increase precedes golgi dispersal, pro-survival autophagy, ER stress, and UPR in fenretinide+ safingol treated neuroblastoma cells N Vad, D Wang, H Cho, D Verlekar, C Linch, CP Reynolds, M Kang, ... Cancer Research 78 (13_Supplement), 2885-2885, 2018 | | 2018 |
| Ceramide synthase-6 binding to CD95/Fas confers resistance to chemotherapy in T-cell acute lymphoblastic leukemia cells DU Verlekar, H Cho, SJ Wei, MH Kang Cancer Research 78 (13_Supplement), 5841-5841, 2018 | | 2018 |
